Group B streptococcus and respiratory syncytial virus immunisation during pregnancy: a landscape analysis. (Q39256577)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28433702%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

title

Group B streptococcus and respiratory syncytial virus immunisation during pregnancy: a landscape analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28433702%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28433702%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Fiona Jane Culley

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28433702%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Kirsty Le Doaré

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28433702%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Marta C Nunes

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28433702%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Manish Sadarangani

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28433702%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Peter Openshaw

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28433702%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

author name string

Christine E Jones

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28433702%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Beate Kampmann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28433702%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Zain Chaudhry

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28433702%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Carol J Baker

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28433702%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

publication date

19 April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28433702%20AND%20SRC:MED&resulttype=core&format=json

Lancet Infectious Diseases

18 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28433702%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28433702%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28433702%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

page(s)

e223-e234

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28433702%20AND%20SRC:MED&resulttype=core&format=json

Maternal and neonatal tetanus

18 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Influenza vaccination of pregnant women and protection of their infants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Effectiveness of maternal pertussis vaccination in England: an observational study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Pertussis and influenza immunisation during pregnancy: a landscape review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Epidemiology of Invasive Group B Streptococcal Disease in the United States, 1999-2005

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Carriage of group B streptococcus in pregnant women from Oxford, UK.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Rapid detection of group B streptococci in pregnant women at delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Group B streptococcal disease in infants: a case control study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Group B streptococcal disease in UK and Irish infants younger than 90 days

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Increased risk for group B Streptococcus sepsis in young infants exposed to HIV, Soweto, South Africa, 2004-2008(1).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Group B Streptococcus and HIV infection in pregnant women, Malawi, 2008-2010

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Incidence of invasive group B streptococcal disease and pathogen genotype distribution in newborn babies in the Netherlands over 25 years: a nationwide surveillance study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Invasive group B streptococcal infection in infants, Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

High burden of invasive Streptococcus agalactiae disease in South African infants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Variation in reported neonatal group B streptococcal disease incidence in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Long-term outcomes of group B streptococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Meningitis in infancy in England and Wales: follow up at age 5 years

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Neonatal severe bacterial infection impairment estimates in South Asia, sub-Saharan Africa, and Latin America for 2010

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Maternal group B Streptococcus-related stillbirth: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Group B Streptococcus β-hemolysin/cytolysin breaches maternal-fetal barriers to cause preterm birth and intrauterine fetal demise in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Membrane Vesicles of Group B Streptococcus Disrupt Feto-Maternal Barrier Leading to Preterm Birth

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Bacterial Hyaluronidase Promotes Ascending GBS Infection and Preterm Birth

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

A hemolytic pigment of Group B Streptococcus allows bacterial penetration of human placenta

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Association between colonization with Group B Streptococcus and preterm delivery: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Missed opportunities for preventing group B streptococcus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Revisiting the Need for Vaccine Prevention of Late-Onset Neonatal Group B Streptococcal Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Characterization of group B streptococci recovered from infants with invasive disease in England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Serotype IV and invasive group B Streptococcus disease in neonates, Minnesota, USA, 2000-2010.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Protection against experimental infection with group B streptococcus by immunization with a bivalent protein vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Multilocus sequence typing system for group B streptococcus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Viral Bronchiolitis in Children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Immunity to RSV in Early-Life.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Respiratory syncytial virus and recurrent wheeze in healthy preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Toward primary prevention of asthma. Reviewing the evidence for early-life respiratory viral infections as modifiable risk factors to prevent childhood asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Respiratory syncytial virus infection in tropical and developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

The burden of respiratory syncytial virus infection in young children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Prevalence and Incidence of Respiratory Syncytial Virus and Other Respiratory Viral Infections in Children Aged 6 Months to 10 Years With Influenza-like Illness Enrolled in a Randomized Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Clinical prediction rule for RSV bronchiolitis in healthy newborns: prognostic birth cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

The epidemiology of respiratory syncytial virus lower respiratory tract infections in children less than 5 years of age in Indonesia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Review on the association of Group B Streptococcus capsular antibody and protection against invasive disease in infants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Maternal antibody at delivery protects neonates from early onset group B streptococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Group B streptococcal colonization and antibody status in lower socioeconomic parturient women

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Natural acquired humoral immunity against serotype-specific group B Streptococcus rectovaginal colonization acquisition in pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Induction of cross-reactive antibodies by immunization of healthy adults with types Ia and Ib group B streptococcal polysaccharide-tetanus toxoid conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Prevalence of respiratory syncytial virus IgG antibodies in infants living in a rural area of Mozambique

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Maternal antibody and respiratory syncytial virus infection in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

The role of neutralizing antibodies in protection of American Indian infants against respiratory syncytial virus disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

The level and duration of RSV-specific maternal IgG in infants in Kilifi Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Antibody response and avidity of respiratory syncytial virus-specific total IgG, IgG1, and IgG3 in young children.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Seasonal variation of maternally derived respiratory syncytial virus antibodies and association with infant hospitalizations for respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Maternal antibodies by passive immunization with formalin inactivated respiratory syncytial virus confer protection without vaccine-enhanced disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

The guinea pig as a model for the study of maternal immunization against respiratory syncytial virus infections in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Mechanisms of immunity to respiratory syncytial virus in cotton rats

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Respiratory syncytial virus and recurrent wheeze

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Quantifying maternally derived respiratory syncytial virus specific neutralising antibodies in a birth cohort from coastal Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Seroepidemiologies of human metapneumovirus and respiratory syncytial virus in young children, determined with a new recombinant fusion protein enzyme-linked immunosorbent assay

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Seroepidemiological study of respiratory syncytial virus in São Paulo state, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Respiratory syncytial virus specific serum antibodies in infants under six months of age: limited serological response upon infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Lower respiratory tract infection caused by respiratory syncytial virus in infants: the role played by specific antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Measurement of antibody against contemporary virus lineages of human respiratory syncytial virus sub-group A in infants and their mothers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Relation of serum antibody to glycoproteins of respiratory syncytial virus with immunity to infection in children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Mucosal IgG Levels Correlate Better with Respiratory Syncytial Virus Load and Inflammation than Plasma IgG Levels

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Nasal Lipopolysaccharide Challenge and Cytokine Measurement Reflects Innate Mucosal Immune Responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Fc gamma receptors in respiratory syncytial virus infections: implications for innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Protective and dysregulated T cell immunity in RSV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Changes in rib cage geometry during childhood

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

The influence of prematurity and low birthweight on transplacental antibody transfer in a rural West African population

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Transplacental transport of IgG antibodies specific for pertussis, diphtheria, tetanus, haemophilus influenzae type b, and Neisseria meningitidis serogroup C is lower in preterm compared with term infants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Respiratory syncytial virus-specific immunoglobulins in preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Antibody against viruses in maternal and cord sera: specific antibody is concentrated on the fetal side of the circulation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Complement fixation and neutralization RS antibodies in maternal and neonatal sera

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Influence of maternal antibodies on neonatal immunization against respiratory viruses.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

The influence of placental malaria infection and maternal hypergammaglobulinemia on transplacental transfer of antibodies and IgG subclasses in a rural West African population

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Anti-group B Streptococcus antibody in infants born to mothers with human immunodeficiency virus (HIV) infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

HIV-1 Is Associated With Lower Group B Streptococcus Capsular and Surface-Protein IgG Antibody Levels and Reduced Transplacental Antibody Transfer in Pregnant Women

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Transplacental or enteral transfer of maternal immunization-induced antibody protects suckling rats from type III group B streptococcal infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Antibodies to type III group B streptococcal polysaccharide in breast milk

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Risk factors for severe respiratory syncytial virus lower respiratory tract infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Risk factors for severe respiratory syncytial virus infection among Alaska native children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Lower interleukin-8 levels in airway aspirates from breastfed infants with acute bronchiolitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Immunoglobulin A antibody response to respiratory syncytial virus structural proteins in colostrum and milk

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Mammary immunity in mothers of infants with respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Secretion of respiratory syncytial virus inhibitors and antibody in human milk throughout lactation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Bronchomammary axis in the immune response to respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Colostrum-derived immunity and maternal-neonatal interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Seasonal variations in maternal serum and mammary immunity to RS virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

A SEROLOGICAL DIFFERENTIATION OF SPECIFIC TYPES OF BOVINE HEMOLYTIC STREPTOCOCCI (GROUP B).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Impaired Chemotaxigenesis by Type III Group B Streptococci in Neonatal Sera: Relationship to Diminished Concentration of Specific Anticapsular Antibody and Abnormalities of Serum Complement

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Maternal Immunization With an Investigational Trivalent Group B Streptococcal Vaccine: A Randomized Controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Effects of alum adjuvant or a booster dose on immunogenicity during clinical trials of group B streptococcal type III conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Capsular switching in group B Streptococcus CC17 hypervirulent clone: a future challenge for polysaccharide vaccine development.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Multilocus sequence typing of invasive group B Streptococcus in central area of Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Molecular epidemiology of group B streptococci in Ireland reveals a diverse population with evidence of capsular switching.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Protective and Harmful Immunity to RSV Infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Current concepts and progress in RSV vaccine development.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Maternal Immunization Earlier in Pregnancy Maximizes Antibody Transfer and Expected Infant Seropositivity Against Pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Introduction of a conjugate meningococcal type C vaccine programme in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Regulatory considerations in the clinical development of vaccines indicated for use during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Vaccine Induced Herd Immunity for Control of Respiratory Syncytial Virus Disease in a Low-Income Country Setting

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Maternal antibodies and infant immune responses to vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Effect of maternal antibody on IgA antibody response in nasopharyngeal secretion in infants and children during primary respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Young infants can develop protective levels of neutralizing antibody after infection with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Efficacy of a modified live intranasal bovine respiratory syncytial virus vaccine in 3-week-old calves experimentally challenged with BRSV.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Local and systemic antibody response to bovine respiratory syncytial virus infection and reinfection in calves with and without maternal antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Antibody dynamics in BRSV-infected Danish dairy herds as determined by isotype-specific immunoglobulins.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

A single vaccination with an inactivated bovine respiratory syncytial virus vaccine primes the cellular immune response in calves with maternal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Bovine respiratory syncytial virus ISCOMs--protection in the presence of maternal antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Intramuscular inoculation of live respiratory syncytial virus induces immunity in cotton rats

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Neonatal immunization with respiratory syncytial virus glycoprotein fragment induces protective immunity in the presence of maternal antibodies in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Protective efficacy against respiratory syncytial virus following murine neonatal immunization with BBG2Na vaccine: influence of adjuvants and maternal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Protective immunity against respiratory syncytial virus in early life after murine maternal or neonatal vaccination with the recombinant G fusion protein BBG2Na

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Priming for local and systemic antibody memory responses to bovine respiratory syncytial virus: effect of amount of virus, virus replication, route of administration and maternal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

T-cell populations responsive to bovine respiratory syncytial virus in seronegative calves

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Maternal immunization with pneumococcal 9-valent conjugate vaccine and early infant otitis media

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis Serogroups A, C, Y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United Kin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Prevention of group B streptococcal disease in the first 3 months of life: would routine maternal immunization during pregnancy be cost-effective?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Respiratory syncytial virus immunization program for the United States: impact of performance determinants of a theoretical vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Cost-effectiveness of potential infant vaccination against respiratory syncytial virus infection in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

Potential Cost-Effectiveness of RSV Vaccination of Infants and Pregnant Women in Turkey: An Illustration Based on Bursa Data

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930232-3

7 January 2021

10.1016/S1473-3099(17)30232-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28433702%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference